Temporal proteome profiling of taxol-induced mitotic arrest and apoptosis

Vibeke H Bull1, Ellen M Fargestad, Margarita Strozynski

  • 1The Biotechnology Centre of Oslo, University of Oslo, Oslo, Norway.

Electrophoresis
|May 28, 2010
PubMed

Insights

Taxol (Paclitaxel) treatment causes protein changes in HeLa cells, revealing spatial shifts in Calumenin, STIP1, and TCTP during mitotic arrest and apoptosis. These findings enhance understanding of cancer therapy mechanisms.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Proteomics

Background:

  • Taxol (Paclitaxel) is a key mitotic inhibitor in cancer therapy.
  • Understanding protein dynamics during drug-induced cellular states is crucial.

Purpose of the Study:

  • To investigate temporal proteome changes in HeLa cells exposed to Taxol.
  • To identify and characterize protein translocations during mitotic arrest and apoptosis.

Main Methods:

  • Temporal proteome profiling of HeLa cells.
  • Immunoblotting and subcellular fractionation for specific proteins.
  • Quantitative analysis of Bim isoforms.

Main Results:

  • Calumenin, STIP1, and TCTP showed distinct subcellular localization changes during Taxol treatment.
  • Calumenin shifted from membranes to cytosol, STIP1 translocated to the nucleus/cytoskeleton, and TCTP localized to cytosol/membranes.
  • Differential expression of Bim isoforms (BimL, BimS, BimEL) was observed.

Conclusions:

  • Temporal proteome profiling effectively assigns proteins to cellular processes like mitotic arrest and apoptosis.
  • Complementary methods revealed spatial protein dynamics crucial for understanding Taxol's mechanism of action.
  • This study provides insights into the complex cellular responses to Taxol therapy.